Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome

Antipsychotic polypharmacy: never say never, but never say always

(2012) Stephen M. Stahl   ACTA PSYCHIATRICA SCANDINAVICA

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report

(2012) Julie Langan et al.   BMC Psychiatry

Retrospective chart review of catatonia in child and adolescent psychiatric patients

(2011) N. Ghaziuddin et al.   ACTA PSYCHIATRICA SCANDINAVICA

International Consensus Study of Antipsychotic Dosing

(2010) David M. Gardner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

(2010) Richard Mailman et al.   CURRENT PHARMACEUTICAL DESIGN

Risk of Neuroleptic Malignant Syndrome in Patients with Bipolar Disorder: A Retrospective, Population-Based Case-Control Study

(2010) Yan Chen et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death

(2010) Ümit Tural et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data

(2009) Robert Stewart et al.   BMC Psychiatry

Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

(2009) Julian N. Trollor et al.   CNS DRUGS